Rapamycin suppresses inflammation and increases the interaction between p65 and IκBα in rapamycin-induced fatty livers
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0281888
Abstract: Rapamycin treatment significantly increases lifespan and ameliorates several aging-related diseases in mice, making it a potential anti-aging drug. However, there are several obvious side effects of rapamycin, which may limit the broad applications of this… read more here.
Keywords: fatty livers; inflammation; fatty liver; rapamycin induced ... See more keywords